INS and early-onset autosomal dominant Alzheimer disease: In addition, the insulin signaling transduction pathway can inhibit Aβ production and the hyperphosphorylation of microtubule-related protein tau through multiple pathways, so impaired insulin signaling can accelerate the progression of Alzheimer’s disease (AD) (8).